These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10754488)

  • 1. Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer.
    Li C; Guo B; Wilson PB; Stewart A; Byrne G; Bundred N; Kumar S
    Int J Cancer; 2000 Mar; 89(2):122-6. PubMed ID: 10754488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of transforming growth factor beta3 in lymphatic metastasis in breast cancer.
    Li C; Wang J; Wilson PB; Kumar P; Levine E; Hunter RD; Kumar S
    Int J Cancer; 1998 Oct; 79(5):455-9. PubMed ID: 9761112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
    Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
    Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis.
    Li C; Wilson PB; Levine E; Barber J; Stewart AL; Kumar S
    Int J Cancer; 1999 Apr; 84(2):155-9. PubMed ID: 10096248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodetection and characterisation of soluble CD105-TGFbeta complexes.
    Li CG; Wilson PB; Bernabeu C; Raab U; Wang JM; Kumar S
    J Immunol Methods; 1998 Sep; 218(1-2):85-93. PubMed ID: 9819125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease.
    Li CG; Bethell H; Wilson PB; Bhatnagar D; Walker MG; Kumar S
    Atherosclerosis; 2000 Sep; 152(1):249-56. PubMed ID: 10996361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.
    Li C; Guo B; Bernabeu C; Kumar S
    Microsc Res Tech; 2001 Feb; 52(4):437-49. PubMed ID: 11170303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential kinetics of plasma CD105 and transforming growth factor beta expression early in human acute pancreatitis.
    Jamdar S; Al-Mowallad AF; Kumar S; Siriwardena AK
    Pancreas; 2006 Mar; 32(2):152-8. PubMed ID: 16552334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
    Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin.
    Takahashi N; Kawanishi-Tabata R; Haba A; Tabata M; Haruta Y; Tsai H; Seon BK
    Clin Cancer Res; 2001 Mar; 7(3):524-32. PubMed ID: 11297243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.
    Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S
    World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells.
    Warrington K; Hillarby MC; Li C; Letarte M; Kumar S
    Anticancer Res; 2005; 25(3B):1851-64. PubMed ID: 16158917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD105 is important for angiogenesis: evidence and potential applications.
    Duff SE; Li C; Garland JM; Kumar S
    FASEB J; 2003 Jun; 17(9):984-92. PubMed ID: 12773481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells.
    Li C; Hampson IN; Hampson L; Kumar P; Bernabeu C; Kumar S
    FASEB J; 2000 Jan; 14(1):55-64. PubMed ID: 10627280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
    Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
    Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.
    Altomonte M; Montagner R; Fonsatti E; Colizzi F; Cattarossi I; Brasoveanu LI; Nicotra MR; Cattelan A; Natali PG; Maio M
    Br J Cancer; 1996 Nov; 74(10):1586-91. PubMed ID: 8932339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation.
    Postiglione L; Di Domenico G; Caraglia M; Marra M; Giuberti G; Del Vecchio L; Montagnani S; Macri M; Bruno EM; Abbruzzese A; Rossi G
    Int J Oncol; 2005 May; 26(5):1193-201. PubMed ID: 15809709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic significance of CD105 mRNA expression in human breast carcinoma].
    Pang D; Liu F; Xue YW; Zhang QF
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):38-40. PubMed ID: 15771797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential levels of soluble endoglin (CD105) in myeloid malignancies.
    Calabrò L; Fonsatti E; Bellomo G; Alonci A; Colizzi F; Sigalotti L; Altomonte M; Musolino C; Maio M
    J Cell Physiol; 2003 Feb; 194(2):171-5. PubMed ID: 12494455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.